发明名称 RETINOID AGONISTS
摘要 Compounds represented by the general formula (I) or salts thereof, having an ability to potentiate the physiological activities of retinoic acid or retinoids: (I) [wherein R<1> is hydrogen or C1-6 alkyl; R<2> and R<3> are each hydrogen, C1-6 alkyl, or the like; R<4>, R<5>, and R<6> are each hydrogen, halogeno, C1-6 alkyl, or the like; Y is phenylene or pyridinediyl; X is S- or N(R<7>)- (wherein R<7> is hydrogen or C1-6 alkyl); and Z is C-R<8> (wherein R<8> is hydrogen, halogeno, or the like) or N], mor e specifically, compounds represented by the general formula (I) or salts thereof [wherein (1) Z is N, or (2) R<1> is hydrogen or C1-6 alkyl; R<2> and R<3> together with the ring-constituent carbon atoms to which they are bonded form a six-membered ring bearing one or more C1-4 alkyl groups; R<4>, R<5>, and R<6> are each hydrogen; Y is pyridinediyl; X is S-; and Z is CH].
申请公布号 WO02055525(A1) 申请公布日期 2002.07.18
申请号 WO2002JP00081 申请日期 2002.01.10
申请人 INSTITUTE OF MEDICINAL MOLECULAR DESIGN. INC.;NAGANO, TATSUO;SAOTOME, TOMOMI;ITAI, AKIKO 发明人 NAGANO, TATSUO;SAOTOME, TOMOMI;ITAI, AKIKO
分类号 A61P3/02;A61P3/10;A61P17/00;A61P17/06;A61P19/00;A61P29/00;A61P35/00;A61P35/02;A61P37/08;A61P43/00;C07D471/04;(IPC1-7):C07D513/04;C07D417/04;C07D243/38;C07D281/10;C07D401/04;C07D281/12;A61K31/554;A61K31/551 主分类号 A61P3/02
代理机构 代理人
主权项
地址
您可能感兴趣的专利